Welcome to our dedicated page for Envista Holdings SEC filings (Ticker: NVST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Envista Holdings Corporation (NYSE: NVST) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed information about its dental products business. As a Delaware-incorporated public company with common stock registered under Commission File Number 001-39054, Envista uses SEC filings to report on financial results, governance changes, and other material events related to its global family of dental brands.
On this page, investors can review Envista’s core periodic reports, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe the company’s segments, such as Specialty Products & Technologies and Equipment & Consumables, along with risk factors, management discussion, and financial statements. Current reports on Form 8-K disclose specific developments, such as quarterly earnings releases, the publication of a Sustainability Report covering environmental, social, and governance topics, and changes in the composition of the Board of Directors.
Envista’s 8-K filings include items reporting results of operations and financial condition, where the company furnishes press releases detailing sales, net income, adjusted EBITDA, and business highlights for recent quarters. Other 8-K items address Regulation FD disclosures, such as slide decks used on earnings calls or references to sustainability and investor presentations, as well as board-level changes like the resignation of a director.
Through Stock Titan, these SEC filings are updated from EDGAR and can be paired with AI-powered summaries that explain key points in accessible language. Users can quickly identify the most relevant sections of Envista’s 10-K and 10-Q reports, understand the implications of 8-K announcements, and access information related to the company’s capital structure and governance. This page also serves as a starting point for tracking any future Forms 4 or proxy materials that may detail insider transactions or executive compensation, as they become available in Envista’s regulatory record.
Franklin Mutual Advisers, LLC, a Delaware investment adviser, filed an amended Schedule 13G reporting its beneficial ownership of Envista Holdings Corp common stock. It reports beneficial ownership of 7,985,856 shares, representing 4.85% of the class as of the event date.
The firm has sole power to vote 7,583,978 shares and sole power to dispose of 7,985,856 shares, with no shared voting or dispositive power. The shares are held in open-end funds and other managed accounts for its clients, who are entitled to dividends and sale proceeds.
The filing states that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Envista. Franklin Mutual Advisers disclaims pecuniary interest and beneficial ownership beyond its role as investment manager.
Morgan Stanley and Atlanta Capital reported sizable stakes in Envista Holdings (NVST) on Schedule 13G/A. As of September 30, 2025, Morgan Stanley reported beneficial ownership of 10,129,212 shares, representing 6.1% of the common stock. Atlanta Capital Management Company, LLC reported 9,057,770 shares, or 5.4%.
Morgan Stanley reported 0 sole voting power and 9,094,952 shared voting power, with 0 sole dispositive power and 9,706,708 shared dispositive power. Atlanta Capital reported 0 sole voting power and 8,134,698 shared voting power, with 0 sole dispositive power and 8,666,417 shared dispositive power. The filing includes a certification that the securities are held in the ordinary course and not for the purpose of changing or influencing control.
Envista Holdings Corp (NVST) CEO and director Paul A. Keel reported a Form 4 transaction. On 11/01/2025, 54,097 shares of common stock were withheld at $20.35 per share to satisfy tax obligations upon the vesting of stock‑settled restricted stock units (Transaction Code F). Following this withholding, Keel beneficially owns 347,555 shares directly.
Envista Holdings (NVST) reported Q3 results with sales of $669.9 million, up from $601.0 million a year ago. Operating profit rose to $57.5 million from $20.9 million as gross profit improved to $370.2 million. Despite pre‑tax income of $49.9 million, the company recorded a net loss of $30.3 million due to income tax expense of $80.2 million, driven primarily by a change in indefinite reinvestment assertions related to a foreign subsidiary.
Specialty Products & Technologies delivered $431.5 million in revenue and Equipment & Consumables $238.4 million. For the nine months, sales were $1,968.9 million, with net income of $14.1 million versus a prior‑year loss that included significant impairments. Cash and equivalents were $1,133.9 million, supported by $167.7 million of operating cash flow. Long‑term debt was $1,445.4 million, reflecting revolver usage and term loans; the company repaid $116.3 million as its 2025 convertible notes matured. Shares outstanding were 164,426,233 as of October 24, 2025.
Envista Holdings Corporation (NVST) furnished a press release announcing financial results for the quarter ended September 26, 2025. The release is provided as Exhibit 99.1.
The company also plans to reference a slide deck during its conference call on October 30, 2025 to discuss these results. The presentation is available on the Investors section of its website. The disclosures under Items 2.02 and 7.01 are being furnished and are not deemed filed.
Envista Holdings Corporation (NVST) furnished an Item 7.01 update announcing the release of its Sustainability Report, highlighting actions and progress across environmental, social, and governance topics. The report is available on the company’s website, and the related press release is furnished as Exhibit 99.1.
The information was furnished, not filed, under Regulation FD, and is incorporated by reference only if specifically referenced in future filings.
Envista Holdings Corporation disclosed that director Barbara B. Hulit resigned from the Board effective September 26, 2025. The resignation was submitted on September 15, 2025, and is to pursue another opportunity. The company stated the departure was not due to any disagreement with the Company on operations, policies, or practices.
Robert Befidi, President, Diagnostics of Envista Holdings Corp (NVST), reported a Form 4 filing showing a non-derivative disposition of 3,454 shares of common stock on 08/25/2025 at a price of $21.12 per share. The filing states these shares were withheld to satisfy tax withholding obligations related to vested restricted stock units. After the transaction, Mr. Befidi beneficially owned 45,504 shares. The Form 4 was signed by Heather Turner by power of attorney on 08/27/2025.
Envista Holdings Corp (NVST) insider sale disclosure: Chief Financial Officer Eric D. Hammes reported the disposition of 7,654 shares of Envista common stock on 08/25/2025 at a reported price of $21.12 per share. After the transaction, Hammes beneficially owned 96,788 shares. The filing explains these shares were withheld to satisfy tax-withholding obligations related to the vesting of stock-settled Restricted Stock Units, indicating the transaction was not an open-market sale but a net settlement of equity awards. The Form 4 was signed by a power of attorney on 08/27/2025.
Stefan Nilsson, an officer and director of Envista Holdings Corp (NVST) and listed as President, Nobel Biocare, reported a routine disposition of the issuer's common stock. On 08/25/2025 Code F activity shows 804 shares were disposed at $21.12 per share. The filing explains these shares were withheld to satisfy tax withholding obligations arising from the vesting of stock-settled Restricted Stock Units. After this transaction Nilsson beneficially owned 54,941 shares in a direct ownership form. The Form 4 was signed by Heather Turner by power of attorney on 08/27/2025.